SCHEMBL29411414

SCHEMBL29411414

Cc1ccc(C(=O)NCCCc2ccc(-c3ccc(N)nc3)cc2)cn1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.57
NAMPT P43490 4/20 0.52
ALDH1A1 P00352 1/20 0.47
CYP19A1 P11511 1/20 0.47
EPHX2 P34913 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
POLB P06746 1/20 0.45
ALOX15 P16050 1/20 0.45
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
PTAFR P25105 3/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045212 1.00 KDM4E (0.57) KDM4ENAMPTALDH1A1CYP19A1EPHX2
SCHEMBL21045190 0.90 KDM4E (0.58) KDM4ENAMPTALDH1A1CYP19A1EPHX2
SCHEMBL21100312 0.86 KDM4E (0.62) KDM4ENAMPTALDH1A1CYP19A1EPHX2
SCHEMBL21100618 0.81 KDM4E (0.55) KDM4ENAMPTALDH1A1CYP19A1EPHX2
SCHEMBL21045469 0.81 KDM4E (0.55) KDM4EALDH1A1CYP19A1EPHX2TDP1
SCHEMBL21045260 0.80 KDM4E (0.52) KDM4ENAMPTALDH1A1CYP19A1TDP1
SCHEMBL21045578 0.80 KDM4E (0.54) KDM4EALDH1A1CYP19A1EPHX2TDP1
SCHEMBL21045084 0.79 CD274 (0.53) KDM4ENAMPTMKNK2
SCHEMBL21045178 0.78 KDM4E (0.55) KDM4ENAMPTALDH1A1CYP19A1EPHX2
SCHEMBL29411410 0.78 KDM4E (0.55) KDM4ENAMPTALDH1A1CYP19A1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB KDM4E 4032/4885NAMPT 778/4885ALDH1A1 3048/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB KDM4E 4032/4885NAMPT 778/4885ALDH1A1 3048/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB KDM4E 4032/4885NAMPT 778/4885ALDH1A1 3048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.